tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Wildlife

tanzania times : Latest News and In-depth Analysis
HomeWildlife
Wildlife

Jan 16, 2025

The Return of Chinatown Mysteries with Detective Chinatown 1900

LOS ANGELES,Jan. 15,2025-- From Bangkok to New York,Tokyo to San Francisco,the Detective Chinatown Universe Continues to Amaze Audiences Worldwide

All News

Klappir and International Carbon Registry (ICR) Announce Strategic Partnership

REYKJAVIK,Iceland,Jan. 15,2025-- The International Carbon Registry (ICR),an innovative GHG program and a modern registry platform for high quality carbon credits,is excited to announce its partnership

Jan 16, 2025

MAX to Exhibit at World of Concrete 2025: Introducing Autonomous Mobile Tying Robot, Rebar Tying Unit for Automation

- Exhibiting Automated Equipment That Aims to Solve Issues in Construction Industry,Including Labor Shortage -

Jan 16, 2025

JX Luxventure Signs Blockbuster USD20,000,0000 Strategic Annual Cooperation Agreement

HAIKOU,China,Jan. 15,2025-- JX Luxventure Group Inc. (Nasdaq: JXG) (the "Company"),a technology company engages in integrated tourism services,including tourism,duty-free cross-border goods,

Jan 16, 2025

Wildlife

Sands China, in Partnership with Alipay and Macau Pass, Successfully Introduced the Innovative Alipay Tap! in Macao

Simplifying payments for both domestic and international tourists MACAO,Jan. 14,2025--On Jan. 14,2025,Sands China Ltd.,Alipay and Macau Pass jointly introduced the Alipay Tap! service at Sands Resorts

Jan 15, 2025

GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability

PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa

Jan 15, 2025

Wildlife

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Jan 15, 2025

1 ... 21 22 23 24 25 26 27 ... 32